| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alain Rios, Satoshi Nonomura, Shigeki Kato, Junichi Yoshida, Natsuki Matsushita, Atsushi Nambu, Masahiko Takada, Riichiro Hira, Kazuto Kobayashi, Yutaka Sakai, Minoru Kimura, Yoshikazu Isomur. Reward expectation enhances action-related activity of nigral dopaminergic and two striatal output pathways. Communications biology. vol 6. issue 1. 2023-09-06. PMID:37673949. |
given the classical basal ganglia model wherein dopamine stimulates dspns and suppresses ispns through distinct dopamine receptors, dopamine might not be the primary driver of ispn activity increasing following higher reward expectation. |
2023-09-06 |
2023-10-07 |
rat |
| Oleg Tolstenkov, Yana Mikhaleva, Joel C Glove. A miniaturized nigrostriatal-like circuit regulating locomotor performance in a protochordate. Current biology : CB. 2023-08-29. PMID:37643617. |
the circuit is reminiscent of the nigrostriatopallidal system in the vertebrate basal ganglia, in which disinhibitory circuits release specific movements under the modulatory control of dopamine. |
2023-08-29 |
2023-09-07 |
Not clear |
| Véronique Coizet, Racha Al Tannir, Arnaud Pautrat, Paul G Overto. Separation of Channels Subserving Approach and Avoidance/Escape at the Level of the Basal Ganglia and Related Brainstem Structures. Current neuropharmacology. 2023-08-18. PMID:37594168. |
this function relies on afferents targeting the main input structures of the basal ganglia, entering bids for action selection at the level of the striatum or sig- nals for behavioral interruption at the level of the subthalamic nucleus, with behavioral reselection facilitated by dopamine signaling. |
2023-08-18 |
2023-09-07 |
Not clear |
| Emil Wärnberg, Arvind Kuma. Feasibility of dopamine as a vector-valued feedback signal in the basal ganglia. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 32. 2023-08-01. PMID:37527344. |
feasibility of dopamine as a vector-valued feedback signal in the basal ganglia. |
2023-08-01 |
2023-08-14 |
Not clear |
| Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakrabort. Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson's disease model. Cell & bioscience. vol 13. issue 1. 2023-08-01. PMID:37528492. |
this leads to depleted dopamine (da) content at striatum, thus affecting the fine tuning of basal ganglia. |
2023-08-01 |
2023-08-14 |
Not clear |
| Michael B Prit. Nuclei and tracts in the epithalamus of crocodiles. The Journal of comparative neurology. 2023-07-29. PMID:37507852. |
the medial component is related to the limbic system and serotonergic raphe, while the lateral nucleus is more interconnected with the basal ganglia and midbrain dopamine systems. |
2023-07-29 |
2023-08-14 |
Not clear |
| Chayaporn Reakkamnuan, Dania Cheaha, Nifareeda Samerphop, Jakkrit Nukitram, Ekkasit Kumarnsi. Differential local field potential oscillations in the dorsal striatum and locomotor activity induced by morphine and haloperidol in mice. Acta neurobiologiae experimentalis. vol 83. issue 2. 2023-07-26. PMID:37493531. |
dopamine (da) depletion in the dorsal striatum underlies symptoms of basal ganglia pathologies, including parkinson's disease (pd). |
2023-07-26 |
2023-08-14 |
mouse |
| Charles Ducrot, Gregory de Carvalho, Benoit Delignat-Lavaud, Constantin V L Delmas, Priyabrata Halder, Nicolas Giguère, Consiglia Pacelli, Sriparna Mukherjee, Marie-Josée Bourque, Martin Parent, LuLu Y Chen, Louis-Eric Trudea. Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons. eLife. vol 12. 2023-07-06. PMID:37409563. |
midbrain dopamine (da) neurons are key regulators of basal ganglia functions. |
2023-07-06 |
2023-08-14 |
mouse |
| Ilene Trinh, Angeni Muralidhar, Justin Yang, Nicolás Phielip. Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease. Movement disorders clinical practice. vol 10. issue 6. 2023-06-19. PMID:37332639. |
a hallmark of parkinson's disease (pd) is progressive loss of dopamine terminals in the basal ganglia, with clinical symptoms including motor and non-motor manifestations such as bradykinesia, rigidity, and cognitive impairment. |
2023-06-19 |
2023-08-14 |
Not clear |
| Cláudia Raquel Marques, Miguel de Almeida Fuzeta, Raquel Medina Dos Santos Cunha, Joana Pereira-Sousa, Deolinda Silva, Jonas Campos, Andreia Teixeira-Castro, Rui Amandi Sousa, Ana Fernandes-Platzgummer, Cláudia L da Silva, António José Salgad. Neurodifferentiation and Neuroprotection Potential of Mesenchymal Stromal Cell-Derived Secretome Produced in Different Dynamic Systems. Biomedicines. vol 11. issue 5. 2023-05-27. PMID:37238911. |
parkinson's disease (pd) is the second most common neurodegenerative disorder and is characterized by the degeneration of the dopamine (da) neurons in the substantia nigra pars compacta, leading to a loss of da in the basal ganglia. |
2023-05-27 |
2023-08-14 |
human |
| M T Herrero, J E Yuste, L Cuenca-Bermejo, P Almela, L Arenas-Betancur, V De Pablos, A Gonzalez-Cuello, E Del Bel, J Navarro-Zaragoza, E Fernández-Villalb. 7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate. Open biology. vol 13. issue 5. 2023-05-16. PMID:37192671. |
nitric oxide (no) plays a pivotal role in integrating dopamine transmission in the basal ganglia and has been implicated in the pathogenesis of parkinson disease (pd). |
2023-05-16 |
2023-08-14 |
monkey |
| Julia Henkel, Christian Hartmann, Valentina Niccolai, Ruben van de Vijver, Alfons Schnitzler, Katja Biermann-Rube. Reduced syntactic recursion in spontaneous speech of Parkinson's disease patients. Acta psychologica. vol 236. 2023-05-06. PMID:37148642. |
our results suggest a contribution of the basal ganglia to language processing, such as syntactic composition, which, however, does not seem to be dopamine dependent. |
2023-05-06 |
2023-08-14 |
Not clear |
| Andrea Ortone, Alberto Arturo Vergani, Mahboubeh Ahmadipour, Riccardo Mannella, Alberto Mazzon. Dopamine depletion leads to pathological synchronization of distinct basal ganglia loops in the beta band. PLoS computational biology. vol 19. issue 4. 2023-04-27. PMID:37104542. |
dopamine depletion leads to pathological synchronization of distinct basal ganglia loops in the beta band. |
2023-04-27 |
2023-08-14 |
human |
| Andrea Ortone, Alberto Arturo Vergani, Mahboubeh Ahmadipour, Riccardo Mannella, Alberto Mazzon. Dopamine depletion leads to pathological synchronization of distinct basal ganglia loops in the beta band. PLoS computational biology. vol 19. issue 4. 2023-04-27. PMID:37104542. |
motor symptoms of parkinson's disease (pd) are associated with dopamine deficits and pathological oscillation of basal ganglia (bg) neurons in the β range ([12-30] hz). |
2023-04-27 |
2023-08-14 |
human |
| Jian-Ya Peng, Zeng-Xin Qi, Qi Yan, Xiu-Juan Fan, Kang-Li Shen, Hui-Wei Huang, Jian-Hua Lu, Xiao-Qin Wang, Xiao-Xia Fang, Liming Mao, Jianguang Ni, Liang Chen, Qian-Xing Zhuan. Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus-thalamus circuitry. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 17. 2023-04-17. PMID:37068253. |
in parkinson's disease (pd), reduced dopamine levels in the basal ganglia have been associated with altered neuronal firing and motor dysfunction. |
2023-04-17 |
2023-08-14 |
mouse |
| Bader Alkharisi, Khaled Dostzada, Harleen Kaur, Manoj Kumar, Jeanne Y Wei, Gohar Azha. The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias. The American journal of case reports. vol 24. 2023-04-05. PMID:37016564. |
to increase the sensitivity of current dlb guidelines, the dlb consortium published its fourth revised report in 2017 with increased diagnostic weight given to dopamine transporter (dat) uptake in the basal ganglia, demonstrated by single-photon emission computed tomography or positron emission tomography imaging. |
2023-04-05 |
2023-08-14 |
Not clear |
| Nicole E Chambers, Michael Millett, Mark S Moehl. The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders. Biochemical Society transactions. 2023-04-04. PMID:37013974. |
this review reappraises the dopamine-acetylcholine balance hypothesis in light of recent evidence and describes how the gαi/o coupled muscarinic m4 receptor acts in opposition to dopamine signaling in the basal ganglia. |
2023-04-04 |
2023-08-14 |
Not clear |
| Elena Garasto, Alessandro Stefani, Mariangela Pierantozzi, Rocco Cerroni, Matteo Conti, Simone Maranesi, Nicola B Mercuri, Agostino Chiaravalloti, Orazio Schillaci, Andrea Viziano, Arturo Moleti, Renata Sist. Association between hearing sensitivity and dopamine transporter availability in Parkinson's disease. Brain communications. vol 5. issue 2. 2023-04-03. PMID:37006327. |
this study investigates the association between the basal ganglia dopamine transporter availability and the hearing function in parkinson's disease patients, focusing also on the lateralization of both dysfunctions, with respect to that of the motor symptoms, and introducing a further distinction between patients with left-sided and right-sided predominant motor symptoms. |
2023-04-03 |
2023-08-14 |
Not clear |
| Christine J Arasaratnam, Jennifer J Song, Tomoko Yoshida, Maurice A Curtis, Ann M Graybiel, Richard L M Faull, Henry J Waldvoge. DARPP-32 cells and neuropil define striosomal system and isolated matrix cells in human striatum. The Journal of comparative neurology. 2023-04-01. PMID:37002560. |
striatal projection neurons (spns) include relatively intermixed populations expressing d1-type or d2-type dopamine receptors (dspns and ispns) that give rise to the direct (d1) and indirect (d2) output systems of the basal ganglia. |
2023-04-01 |
2023-08-14 |
human |
| Hyeon-Man Bae. Diffusion Measures of Subcortical Structures Using High-Field MRI. Brain sciences. vol 13. issue 3. 2023-03-29. PMID:36979201. |
the pathology of parkinson's disease (pd) involves the death of dopaminergic neurons in the substantia nigra (sn), which slowly influences downstream basal ganglia pathways as dopamine transport diminishes. |
2023-03-29 |
2023-08-14 |
human |